Further analysis of epidermis barrier function revealed that Muc16,[29] which encodes an epithelial protein marked as compromised barrier function in psoriasis, was significantly downregulated following nor@MSC‐EVs treatment compared to PBS. This evidence concerns the gene MUC16 and psoriasis.